您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报 (医学版) ›› 2020, Vol. 58 ›› Issue (7): 82-88.doi: 10.6040/j.issn.1671-7554.0.2020.0261

• • 上一篇    

胫骨高位截骨术联合自体脂肪间充质干细胞注射在膝关节软骨修复中的应用

李松林1,刘培来1,卢群山1,马贺然2,3   

  1. 1. 山东大学齐鲁医院骨科, 山东 济南 250012;2. 山东省齐鲁细胞治疗工程技术有限公司, 山东 济南 250000;3. 山东银丰生命科学研究院, 山东 济南 250000
  • 发布日期:2020-07-10
  • 通讯作者: 刘培来. E-mail:gklpl@163.com
  • 基金资助:
    山东省重点研发计划(2016GSF201081);山东大学横向课题(12671818)

Application of high tibial osteotomy combined with autologous adipose-derived mesenchymal stem cells injection in the repair of knee cartilage

LI Songlin1, LIU Peilai1, LU Qunshan1, MA Heran2,3   

  1. 1. Department of Orthopaedics, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250012, Shandong, China;
    2. Qilu Cell Therapy Technology Co., Ltd, Jinan 250000, Shandong, China;
    3. Shandong Yinfeng Life Science Research Institute, Jinan 250000, Shandong, China
  • Published:2020-07-10

摘要: 目的 探讨胫骨高位截骨术联合自体脂肪间充质干细胞注射对膝关节骨关节炎患者软骨修复的效果。 方法 分析行胫骨高位截骨术联合自体脂肪间充质干细胞注射治疗膝关节骨关节炎患者2例的临床资料,以及术前与术后1年的X线及磁共振(MRI),两次关节镜探查情况,术前与术后1年的疼痛视觉模拟评分及膝关节功能评分,评估此种治疗方式对膝关节软骨修复的效果及膝关节功能的改善情况。 结果 2例患者术前MRI及术中关节镜提示膝关节软骨损伤,行胫骨高位截骨术联合自体脂肪间充质干细胞关节腔注射治疗,术后1年患者膝关节功能恢复良好,行MRI及二期关节镜探查见关节软骨较术前再生。 结论 行胫骨高位截骨术的膝关节骨关节炎患者,联合自体脂肪间充质干细胞注射可有效促进膝关节软骨修复,改善患者膝关节功能。

关键词: 膝关节骨关节炎, 胫骨高位截骨术, 干细胞, 软骨修复, 保膝

Abstract: Objective To evaluate the efficacy of high tibial osteotomy(HTO)combined with autologous adipose-derived mesenchymal stem cells injection on cartilage repair in patients with knee osteoarthritis. Methods The clinical data of 2 patients with knee osteoarthritis treated with HTO combined with autologous adipose-derived mesenchymal stem cells injection were retrospectively analyzed, including preoperative and postoperative 1-year X-ray and MRI data, arthroscopic results, visual analogue score, and knee joint function score, so as to evaluate the effects on knee cartilage repair and knee joint function improvement. Results Preoperative MRI and intraoperative arthroscopy indicated knee cartilage injury in both patients. HTO combined with intra-articular injection of autologous adipose-derived mesenchymal stem cells was performed. Knee joint function recovered well 1 year after operation and articular cartilage regenerated. Conclusion For patients with knee osteoarthritis, HTO combined with autologous adipose-derived mesenchymal stem cells injection can effectively promote the repair of knee cartilage and improve the function of knee joint.

Key words: Knee osteoarthritis, High tibial osteotomy, Stem cells, Cartilage repair, Knee preservation

中图分类号: 

  • R684
[1] 中华医学会骨科学分会关节外科学组. 骨关节炎诊疗指南(2018年版)[J]. 中华骨科杂志, 2018, 38(12): 705-715.
[2] 黄野. 胫骨高位截骨术治疗膝关节骨关节炎的现状[J]. 中华关节外科杂志(电子版), 2016, 10(5): 470-473.
[3] 张圣扬, 吕帅洁, 丁权威, 等. 自体脂肪干细胞关节腔内注射治疗膝关节骨关节炎的随机对照研究[J]. 中华骨科杂志, 2018, 38(23): 1426-1434. ZHANG Shengyang, LYU Shuaijie, DING Quanwei, et al. Intra-articular injection of autologous adipose-derived stem cells for knee osteoarthritis: a randomized controlled trial [J]. Chinese Journal of Orthopaedics, 2018, 38(23): 1426-1434.
[4] Zhuo Q, Yang W, Chen J, et al. Metabolic syndrome meets osteoarthritis [J]. Nat Rev Rheumatol, 2012, 8(12): 729-737.
[5] Gupta S, Hawker GA, Laporte A, et al. The economic burden of disabling hip and knee osteoarthritis(OA)from the perspective of individuals living with this condition [J]. Rheumatology(Oxford), 2005, 44(12): 1531-1537.
[6] Issa SN, Sharma L. Epidemiology of osteoarthritis: an update [J]. Curr Rheumatol Rep, 2006, 8(1): 7-15.
[7] 金哲峰, 刘爱峰, 王平, 等. 膝关节骨性关节炎生物力学模型及其软骨表面应力分析[J].中国组织工程研究, 2015, 19(29): 4629-4633.
[8] Chalmers BP, Limberg AK, Tibbo ME, et al. Total knee arthroplasty after high tibial osteotomy results in excellent long-term survivorship and clinical outcomes [J]. J Bone Joint Surg Am, 2019, 101(11): 970-978.
[9] Martay JL, Palmer AJ, Bangerter NK, et al. A preliminary modeling investigation into the safe correction zone for high tibial osteotomy [J]. Knee, 2018, 25(2): 286-295.
[10] Schuster P, Geβlein M, Schlumberger M, et al. Ten-year results of medial open-wedge high tibial osteotomy and chondral resurfacing in severe medial osteoarthritis and varus malalignment [J]. Am J Sports Med, 2018, 46(6): 1362-1370.
[11] Jung WH, Takeuchi R, Chun CW, et al. Second-look arthroscopic assessment of cartilage regeneration after medial opening-wedge high tibial osteotomy [J]. Arthroscopy, 2014, 30(1): 72-79.
[12] Wakabayashi S, Akizuki S, Takizawa T, et al. A comparison of the healing potential of fibrillated cartilage versus eburnated bone in osteoarthritic knees after high tibial osteotomy: An arthroscopic study with 1-year follow-up [J]. Arthroscopy, 2002, 18(3): 272-278.
[13] Kong L, Zheng LZ, Qin L, et al. Role of mesenchymal stem cells in osteoarthritis treatment [J]. J Orthop Translat, 2017, 9: 89-103. doi: 10.1016/j.jot.2017.03.006.
[14] Centeno CJ, Busse D, Kisiday J, et al. Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells [J]. Pain Physician, 2008, 11(3): 343-353.
[15] Koh YG, Kwon OR, Kim YS, et al. Comparative outcomes of open-wedge high tibial osteotomy with platelet-rich plasma alone or in combination with mesenchymal stem cell treatment: a prospective study [J]. Arthroscopy, 2014, 30(11): 1453-1460.
[16] Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice [J]. Lancet, 2011, 377(9783): 2115-2126.
[17] Lories RJ, Luyten FP. The bone-cartilage unit in osteoarthritis [J]. Nat Rev Rheumatol, 2011, 7(1): 43-49.
[18] Diekman BO, Guilak F. Stem cell-based therapies for osteoarthritis: challenges and opportunities [J]. Curr Opin Rheumatol, 2013, 25(1): 119-126.
[19] Ludin A, Sela JJ, Schroeder A, et al. Injection of vascular endothelial growth factor into knee joints induces osteoarthritis in mice [J]. Osteoarthritis Cartilage, 2013, 21(3): 491-497.
[20] Fodor PB, Paulseth SG. Adipose derived stromal cell(ADSC)injections for pain management of osteoarthritis in the human knee joint [J]. Aesthet Surg J, 2016, 36(2): 229-236.
[21] Damia E, Chicharro D, Lopez S, et al. Adipose-derived mesenchymal stem cells: Are they a good therapeutic strategy for osteoarthritis? [J]. Int J Mol Sci, 2018, 19(7): E1926.
No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!